Disc Medicine, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -6.83M-2.16M-0.57M
Gross Profit -6.83M-2.16M-0.57M
Operating items
Research & Development 28.17M48.72M33.44M69.26M96.67M
Selling, General & Administrative 5.87M20.29M14.04M21.86M33.05M
Operating Expenses 34.04M69.00M47.48M91.12M129.72M
Operating Income -34.04M-69.00M-47.48M-91.12M-129.72M
EBIT -34.04M-69.00M-47.48M-91.12M-129.72M
Non-operating items
Interest & Investment Income 0.04M0.01M0.71M14.80M21.29M
Other Non Operating Income -0.01M-0.06M-0.00M-0.00M
Non Operating Income -0.01M0.65M14.79M20.72M
Net income details
EBT -40.83M-71.14M-46.83M-76.33M-109.00M
Tax Provisions 0.10M0.35M
Profit After Tax -40.84M-71.87M-46.83M-76.43M-109.36M
Income from Continuing Operations -40.83M-71.14M-46.83M-76.43M-109.36M
Consolidated Net Income -40.83M-71.14M-46.83M-76.43M-109.36M
Income towards Parent Company -40.83M-71.14M-46.83M-76.43M-109.36M
Net Income towards Common Stockholders -40.83M-71.14M-46.83M-76.43M-109.36M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 1.55M4.31M4.33M24.14M29.76M
EBITDA -34.04M-69.00M-47.48M-91.12M-129.72M